Key result
hs-TnT > 35 ng/L is linked to ~195% higher 30-day mortality in acute heart failure.
Why the study?
High-sensitive troponin T (hs-TnT) is often used qualitatively rather than quantitatively to stratify prognosis in acute heart failure, prompting the search for the optimal hs-TnT cut-off to predict 30-day all-cause mortality.
Does an hs-TnT level > 35 ng/L predict increased 30-day all-cause mortality in patients with acute heart failure?
Cohort (n=3,190)
Does an hs-TnT level > 35 ng/L predict increased 30-day all-cause mortality in patients with acute heart failure?
An hs-TnT cut-off of 35 ng/L effectively predicts 30-day all-cause mortality in acute heart failure patients, offering a high negative predictive value of 95.3%.
hs-TnT >35 ng/L may refine short-term mortality risk stratification in acute HF; leaves open whether thresholds should guide management.
BACKGROUND: Acute heart failure (AHF) patients with high troponin levels have a worse prognosis. High-sensitive troponin T (hs-TnT) has been used as a tool to stratify prognosis in many scales but always as a qualitative and not as a quantitative variable. OBJECTIVES: The main objective of this study was to determine the best hs-TnT cut-off for prediction of 30-day all-cause mortality. METHODS: The EAHFE registry, a prospective follow-up cohort of patients with AHF, was analysed. We performed a propensity score analysis of the optimal hs-TnT cut-off point previously determined by receiver operating characteristic (ROC) curve analysis. RESULTS: Of the 13 791 patients in the EAHFE cohort, we analysed 3190 patients in whom hs-TnT determination was available. The area under the ROC curve for 30-day all-cause mortality was 0.70 (CI95% 0.68 to 0.71; P < .001), establishing an optimal cut-off of hs-TnT of 35 ng/L. The sensitivity and specificity of this cut-off were 76.2 and 55.5%, respectively, with a negative predictive value (NPV) of 95.3%. A propensity score was made with 34 variables showing differences based on the cut-off of 35 ng/L for hs-TnT. In the analysis of the population obtained with the propensity score, patients with hs-TnT > 35 ng/L showed a greater 30-day all-cause mortality, with a HR of 2.95 (CI95% 1.83-4.75; P < .001). External validation reported similar results. CONCLUSIONS: An hs-TnT value of 35 ng/L is an adequate cut-off to evaluate the prediction of 30-day all-cause mortality with a NPV of 95.3%.
No takes yet. Share an insight, caveat, or question.
Roset et al. (2020) conducted a cohort in Acute heart failure (AHF) (n=3,190). hs-TnT > 35 ng/L vs. hs-TnT ≤ 35 ng/L was evaluated on 30-day all-cause mortality (HR 2.95, 95% CI 1.83-4.75, p=< .001). In patients with acute heart failure, an hs-TnT level > 35 ng/L was associated with significantly greater 30-day all-cause mortality (HR 2.95; 95% CI 1.83-4.75; P < .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: